Literature DB >> 6275862

Evidence of a generalized metabolic defect in patients with hereditary chondrocalcinosis. Increased inorganic pyrophosphate in cultured fibroblasts and lymphoblasts.

G Lust, G Faure, P Netter, A Gaucher, J E Seegmiller.   

Abstract

A gene in the heterozygous state appears responsible for a 2-fold increase in pyrophosphate content of both fibroblasts and lymphoblasts cultured from patients who have dominantly inherited chondrocalcinosis. Cells from unaffected family members of this large kindred showed a pyrophosphate content in the same range as was found in unaffected, unrelated controls. Similar cells from individuals homozygous for the gene would be useful in delineating the precise biochemical abnormality responsible for the increased pyrophosphate content.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6275862     DOI: 10.1002/art.1780241210

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  13 in total

Review 1.  Familial and clinical aspects of calcium pyrophosphate deposition disease.

Authors:  A J Reginato; E Tamesis; P Netter
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

Review 2.  Calcium Pyrophosphate Deposition Disease.

Authors:  Ann K Rosenthal; Lawrence M Ryan
Journal:  N Engl J Med       Date:  2016-06-30       Impact factor: 91.245

3.  Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.

Authors:  L J Andrew; V Brancolini; L S de la Pena; M Devoto; F Caeiro; R Marchegiani; A Reginato; A Gaucher; P Netter; P Gillet; D Loeuille; D J Prockop; A Carr; B F Wordsworth; M Lathrop; S Butcher; E Considine; K Everts; A Nicod; S Walsh; C J Williams
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

4.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 5.  Crystals, joints, and consternation.

Authors:  D McCarty
Journal:  Ann Rheum Dis       Date:  1983-06       Impact factor: 19.103

Review 6.  Pyrophosphate arthropathy--recent clinical advances.

Authors:  M Doherty
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 7.  Pathogenesis of chondrocalcinosis and pseudogout. Metabolism of inorganic pyrophosphate and production of calcium pyrophosphate dihydrate crystals.

Authors:  A Caswell; D F Guilland-Cumming; P R Hearn; M K McGuire; R G Russell
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

8.  Histological study of a case of recurrent olecranon bursitis with mixed calcium pyrophosphate dihydrate and apatite crystal deposits.

Authors:  R Lagier; G Boivin; D Lacotte; J C Gerster
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

9.  Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts. Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease.

Authors:  L M Ryan; R L Wortmann; B Karas; M P Lynch; D J McCarty
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 10.  Calcium pyrophosphate dihydrate and hydroxyapatite crystal deposition in the joint: new developments relevant to the clinician.

Authors:  Salih Pay; Robert Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.